1. Home
  2. CNSP vs SOBR Comparison

CNSP vs SOBR Comparison

Compare CNSP & SOBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CNSP
  • SOBR
  • Stock Information
  • Founded
  • CNSP 2017
  • SOBR 2004
  • Country
  • CNSP United States
  • SOBR United States
  • Employees
  • CNSP N/A
  • SOBR N/A
  • Industry
  • CNSP Biotechnology: Pharmaceutical Preparations
  • SOBR Newspapers/Magazines
  • Sector
  • CNSP Health Care
  • SOBR Consumer Discretionary
  • Exchange
  • CNSP Nasdaq
  • SOBR Nasdaq
  • Market Cap
  • CNSP 4.0M
  • SOBR 3.4M
  • IPO Year
  • CNSP 2019
  • SOBR N/A
  • Fundamental
  • Price
  • CNSP $7.20
  • SOBR $1.60
  • Analyst Decision
  • CNSP Strong Buy
  • SOBR
  • Analyst Count
  • CNSP 1
  • SOBR 0
  • Target Price
  • CNSP $20.00
  • SOBR N/A
  • AVG Volume (30 Days)
  • CNSP 13.8K
  • SOBR 29.1K
  • Earning Date
  • CNSP 11-17-2025
  • SOBR 11-12-2025
  • Dividend Yield
  • CNSP N/A
  • SOBR N/A
  • EPS Growth
  • CNSP N/A
  • SOBR N/A
  • EPS
  • CNSP N/A
  • SOBR N/A
  • Revenue
  • CNSP N/A
  • SOBR $364,164.00
  • Revenue This Year
  • CNSP N/A
  • SOBR N/A
  • Revenue Next Year
  • CNSP N/A
  • SOBR N/A
  • P/E Ratio
  • CNSP N/A
  • SOBR N/A
  • Revenue Growth
  • CNSP N/A
  • SOBR 98.07
  • 52 Week Low
  • CNSP $4.93
  • SOBR $1.27
  • 52 Week High
  • CNSP $114.00
  • SOBR $58.00
  • Technical
  • Relative Strength Index (RSI)
  • CNSP 46.98
  • SOBR 27.39
  • Support Level
  • CNSP $6.30
  • SOBR $1.27
  • Resistance Level
  • CNSP $7.07
  • SOBR $2.92
  • Average True Range (ATR)
  • CNSP 0.59
  • SOBR 0.24
  • MACD
  • CNSP 0.06
  • SOBR -0.10
  • Stochastic Oscillator
  • CNSP 34.80
  • SOBR 18.79

About CNSP CNS Pharmaceuticals Inc.

CNS Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma. Glioblastomas are tumors that arise from astrocytes, which are star-shaped cells that make up the supportive tissue of the brain.

About SOBR SOBR Safe Inc.

Sobr Safe Inc provides non-invasive technology to quickly and humanely identify the presence of alcohol in individuals. Its technologies are integrated within robust and scalable data platform, producing statistical and measurable user and business data. It developed the scalable, patent-pending ea4 software platform for non-invasive alcohol detection and identity verification, a solution that has current and potential applications. It generates revenue through various combinations of software products and services which include the sale of cloud-based software solutions, detection and data collection hardware devices, and cloud-based data reporting and analysis services.

Share on Social Networks: